The overnight hypoglycaemia event rate was comparably low with both closed-loop and open-loop insulin delivery devices in the present study, and the amount of time spent in hypoglycaemia below 3.3 mmol/l or below 3.9 mmol/l was very low. This evidence concerns the gene INS and Hypoglycemia.